Although the major urinary metabolites of cortisol 1 have been identified (1-9) and quantitatively estimated (1, 10-13) in man, kinetic aspects related to the formation of these metabolites have been less clearly defined. In a previous publication (14) the pathways of formation, metabolite pool sizes, and the rates of formation of the metabolites of cortisol in two normal humans have been reported. The general method was the administration of a small quantity of cortisol-4-C14 during a steady-state condition (with reference to cortisol turnover) and the determination of the specific activities of cortisol and its metabolites in consecutive 15-minute urine samples. Equations expressing turnover of cortisol and rates of metabolite formation (15) were subsequently applied to these data. * Work supported in part by U. S. Public Health Service grant A-3164 to Harvard University; in part by grants from the Medical Foundation, Inc. and the American Legion Child Welfare Foundation to the Children's Hospital; in part by a contract with the Advisory Committee on Metabolism, Office of the Surgeon General, Department of the Army; and in part by a contract with the Atomic Energy Commission to the Peter Bent Brigham Hospital, Boston, Mass.
Although the major urinary metabolites of cortisol 1 have been identified (1) (2) (3) (4) (5) (6) (7) (8) (9) and quantitatively estimated (1, (10) (11) (12) (13) in man, kinetic aspects related to the formation of these metabolites have been less clearly defined. In a previous publication (14) the pathways of formation, metabolite pool sizes, and the rates of formation of the metabolites of cortisol in two normal humans have been reported. The general method was the administration of a small quantity of cortisol-4-C14 during a steady-state condition (with reference to cortisol turnover) and the determination of the specific activities of cortisol and its metabolites in consecutive 15-minute urine samples. Equations expressing turnover of cortisol and rates of metabolite formation (15) were subsequently applied to these data. * Work supported in part by U. S. Public Health Service grant A-3164 to Harvard University; in part by grants from the Medical Foundation, Inc. and the American Legion Child Welfare Foundation to the Children's Hospital; in part by a contract with the Advisory Committee on Metabolism, Office of the Surgeon General, Department of the Army; and in part by a contract with the Atomic Energy Commission to the Peter Bent Brigham Hospital, Boston, Mass. I The compounds referred to are: cortisol or F, 11p3,-17a,21-trihydroxy-4-pregnene-3,20-dione; THF, 3a,11f,-17a,21-tetrahydroxy-5p8-pregnane-20-one; allo-THF, 3a,-1l,,17a,21-tetrahydroxy-5a-pregnane-20-one; THE, 3a,-17a,21-trihydroxy-5p-pregnane-11,20-dione; cortol, 3a,-11,,17a,20a or p,21-pentahydroxy-5,8-pregnane; cortolone, 3a,17a,20a or ,3,21-tetrahydroxy-5j3-pregnane-11-one; cortisone or E, 17a,21-dihydroxy-4-pregnene-3,11,20-trione; 6p-hydroxycortisol or 6,-OH-F, 6fl,11,6,17a,21-tetrahydroxy-4-pregnene-3,20-dione; 6,8-hydroxycortisone or 6#-OH-E, 6 ,p,17a,21 -trihydroxy -4-pregnene -3,11,20 -trione; 20a-DHF, 11,,17ca,20a,21-tetrahydroxy-4-pregnene-3-one; To aid in the interpretation and applicability of such kinetic measurements, it seemed advisable to carry out further studies in man using similar techniques in which cortisol turnover was fixed by administration of a continuous infusion so that the calculated kinetic parameters could be compared with the known turnover rate. The patient chosen for study was a 23-year-old woman who, 6 weeks before the initial study, had had a subtotal adrenalectomy as treatment for Cushing's syndrome associated with adrenal hyperplasia. From the time of subtotal adrenalectomy to the time of the studies reported, the patient required cortisone as adrenal maintenance therapy. The initial observations of cortisol metabolism were obtained 24 hours after a surgical procedure, cholecystectomy. A similar study was repeated 4 months later when the patient appeared totally recovered from the cholecystectomy. In this paper, a comparison of kinetic parameters is made with reference to the low recovery of urinary cortisol metabolites, and attention is called to the low excretion of the 5a isomer, allo-THF, which we have reported to occur in Cushing's syndrome associated with adrenal hyperplasia (16) 24 hours was begun, and was maintained throughout both surgery and the ensuing 24-hour period (Figure 1 ).
The initial study was carried out on the day after surgery (post-operative period). A small dose of cortisol-4-C14 (9.39 X 10' cpm, approximately 1 ,uc, 234 ug) was administered intravenously over approximately 3 minutes to the patient while she was receiving the constant infusion of cortisol. Urine volume was maintained with an intravenous saline drip, and samples were collected at 15-minute intervals by means of an indwelling catheter. Three plasma samples were taken during the kinetic study to check on the steady-state condition (see Figure  1 ). Specific activities, in counts per minute per microgram, of cortisol and its metabolites were determined in each urine sample and expressed as a function of time, corresponding to the mid-point of the period of urine collection. Pool sizes and pathways were determined by isotope dilution procedures after the intravenous administration of small amounts of unlabeled cortisol metabolites in a manner previously described (14) .
The second study was carried out 4 months later when the patient had totally recovered from the cholecystectomy (control period). During the intervening 4 months it was found necessary to maintain the patient on a daily oral dose of 37.5 mg cortisone and 0.1 mg 9a-fluorocortisol. The procedure followed was identical to that carried out during the post-operative period. The cortisol-4-C1' administered was 1.56 X 10' cpm, approximately 1.5 ,uc and 375 ,tg.
2 Solu-Cortef, sodium salt of cortisol hemisuccinate, Upjohn Co., Kalamazoo, Mich. Steroids administered.3 The techniques employed in purifying and preparing the cortisol-4-C1' and the metabolites THF, THE, and 1-cortolone administered intravenously in these studies have been described previously (14) .
Analytic methods. Plasma and urine samples were kept frozen until used. Extractions were performed as previously described (14) with the following exceptions. a) After an initial triple chloroform extraction to yield "free" metabolites, urines were further extracted 3 times with double volumes of ethyl acetate to obtain the free 6ff-hydroxycortisol (6) . b) The residual urine was adjusted to pH 5 and incubated overnight at 470 C with f-glucuronidase 4 added to a final concentration of 1,000 Fishman units per ml. The glucuronide fraction containing THF, allo-THF, THE, and cortolone was prepared by extracting the incubated urine 3 times with double volumes of chloroform and washing quickly twice with 0.05 volumes 0.01 N sodium hydroxide and once with 0.05 volume water. c) In those instances in which cortol was determined, the urine was extracted as above, but the alkaline and water washes were omitted, since such treatment decreased the yield. Instead, purification was achieved by passing the chloroform extract through a Florisil column as described by Nelson and Samuels (17) . The The residue was chromatographed overnight at 320 C in the descending system, 9 per cent butanol in benzene: 50 per cent aqueous methanol. The 6#-hydroxycortisol area, readily located by scanning in the ultraviolet (235 mju), was subsequently eluted and estimated with the phenylhydrazine reagent, with cortisol as a quantitative standard. Further characterization of the 6p8-hydroxycortisol-4-C14 was achieved, with methods similar to those described previously (20) , by combining eluted with authentic unlabeled 6fi-hydroxycortisol and re-chromatographing in a single narrow channel. Each centimeter of chromatogram was subsequently eluted into clean nickelplated steel planchets, dried, counted, and transferred, with filtration through coarse micro sintered-glass funnels, to 12 X 75 mm culture tubes for the phenylhydrazine reaction. The coincidence of radioactivity and steroid content for 6#-hydroxycortisol is shown in Figure 8 .
Plasma cortisol concentrations were determined by a chromatographic procedure employing isotope dilution with cortisol-4-C"4. To a known volume of plasma (approximately 10 ml), 0.1 ml of an ethanolic solution of cortisol-4-C'4 containing 3.4 jug cortisol and 1.08 X 10' cpm was added. After thorough mixing, the plasma was extracted with chloroform in the same manner as the urine glucuronides. The residue was applied to Whatman no. 1 paper strips, which had been washed with ethanol in a Soxhlet extractor for 24 to 48 hours, while the paper was still moist with ethanol. The trips were placed in the chromatography tank as rapidly as possible to prevent drying the chromatography paper. Chromatography was performed in the toluene: 75 per cent methanol in water system, at 320 C, overnight. The cortisol areas were located by ultraviolet absorption as well as by adjacent standard cortisol migrations. These areas were eluted immediately to known volume with ethanol. Aliquots were taken for fluorometric estimation of cortisol by the procedures outlined by Sweat (21) and Peterson and Wyngaarden (22) . Aliquots also were taken for radioactivity determinations. Plasma concentrations of cortisol were calculated from the change in the specific activity of the cortisol thus determined.
Urinary cortisol specific activities were obtained by chromatographing the urine free chloroform extract in the same manner as the plasma cortisol extracts. Sufficient cortisol was present in the urine samples to permit the use of the phenylhydrazine reagent for quantitative estimation.5 6 Fukushima and co-workers (9), employing reverse isotope dilution techniques, with normal adult urine extracts, have stated that only half of the radioactivity present in the cortisol area on paper chromatograms was in this hormone. The data obtained in the current study Radioactive determinations were made in a NuclearChicago D-47 windowless flow counter at infinite thinness, with the exceptions of those instances in which 1-cm strips of chromatograms were counted directly and where recovery experiments from urine were performed. In the latter experiments appropriate corrections were made for C14-beta radiation self-absorption. For specific activity determinations, expressed as counts per minute per microgram, samples were counted in duplicate with a maximal probable error of 3 per cent. Background was 20 cpm.
RESULTS
Plasma cortisol concentration and the steady state. The plasma concentrations of cortisol at various times during the experimental periods are illustrated in Figure 1 . With the exception of the single elevated level immediately after operation, the values are remarkably constant before and after surgery and during the control period. These data are consistent with steady-state conditions prevailing during the post-operative and control periods. The mean plasma cortisol concentrations are 26 ug per cent during the control period and 33 Mug per cent during the post-operative period.
Cortisol pool sizes and half-lives are shown in Figure 2 .
Turnover of cortisol. Plots of the logarithm of the urinary cortisol specific activity as a function of time for the post-operative period and control period, both 8 hours long, are shown in Figure 2. Inasmuch as both curves exhibited firstorder decay characteristics, half-lives, pool sizes, and turnovers were calculated for cortisol as described previously (14) , and are listed in Figure  2 . There is excellent agreement between the actual rate of infusion of cortisol and the turnover of cortisol calculated from the slope of the specific activity curve.
It is interesting to note in the plot of the data of the post-operative period in Figure 2 that if a suggest either that no such contamination of the cortisol occurred, or that if a contaminant was present, its properties and specific activity are similar to cortisol. It must be emphasized that in this study, urines were extracted before hydrolysis to obtain the cortisol fraction in contrast to extraction after hydrolysis as reported by Fukushima and co-workers (9) . Metabolites existing as glucuronides and having the mobility of cortisol may be released by ,B-glucuronidase. On previous occasions (14) the specific activity of cortisol calculated with the PorterSilber reaction gave identical results with that calculated by the more specific fluorescent technique of Sweat (20) . cortisol half-life t1 were calculated from the slope during the first 2 to 3 hours of the study, it would have been markedly different (approximately 54 minutes) from that obtained using the slope after 2 hours. It is the half-life of 90 minutes that is characteristic of the steady state. The delay in apparent mixing of cortisol-4-C14 in the post-operative study is striking, and is accompanied by a somewhat longer cortisol half-life and larger cortisol pool than are observed in the control study.
It was possible further to confirm that the turnover of cortisol coincided with the infusion rate by applying a form of isotope dilution equation, p = C/SAm, hereafter referred to as the integral specific activity equation, where p is the rate of turnover of cortisol, C is the counts per minute of cortisol administered at time zero, and SAm is the specific activity of a metabolite derived exclusively from cortisol (23) . SAm is determined from a urine pool collected over a period sufficiently long to insure almost complete excretion of radioactivity. The specific activity of the allo-THF in the post-operative period is shown in Figure 3 , and it can be seen that the major portion of the radioactivity has already been excreted by 8 hours; therefore, only a small extrapolation of the curve (see shaded area) was necessary to compute the specific activity of allo-THF for a 24-hour urine pool. Under these steady-state conditions of the experiment, the calculations shown in Figure 3 are permissible. The 24-hour turnover rate of 203 mg agrees well (a 15 per cent difference not considered significant) with both the amount of cortisol infused per 24 hours, 200 mg, and the turnover rate, 232 mg, calculated from the slope of the cortisol curve of Figure 2 . Similarly, the 24-hour turnover of cortisol in the control period calculated by the integral specific activity method applied to 6,/-hydroxycortisol was 177 mg (see Figure 9 ). This agreed well with the amount of cortisol infused per 24 hours, 200 mg, and the value of 187 mg calculated from the slope of the cortisol curve of Figure 2 .
Metabolite specific activities. The chromatographic separation of the major cortisol metabolites is illustrated in Figure 4 for the 15-minute urine sample of the control period collected 300 minutes after cortisol-4-C14 administration. There is a close correspondence for the values of radioactivity and amount in micrograms for THF (III), allo-THF (IV), and THE (V). Portions of peaks III and V were oxidized with sodium bismuthate (24) and the products chromatographed as shown in Figure 5 . The values for radioactivity and amount in micrograms again coincided, the specific activity was essentially the same as that of the C21 parent steroid, and the products formed from THF and THE migrated with 11,8-hydroxyetiocholanolone and 11-keto-etiocholanolone, respectively. A small amount of 11-keto-etiocholanolone is discernible in chromatogram A of Figure 5 and is due to some oxidation of the 11-hydroxyl group by bismuthate.
The specific activities of the four cortisol metabolites, THF, allo-THF, THE, and cortolone are presented in Figure 6 , a-d. Both the control and post-operative curves for each metabolite, together with a segment of the respective cortisol specific activity curves, are shown in each of the four graphs comprising Figure 6 . The times of administration of the unlabeled metabolites used in the isotope dilution calculations in both the postoperative and control periods are indicated by the vertical lines at 2, 4, and 6 hours. A striking feature is the similarity in the over-all appearance of the post-operative and control curves for each metabolite. The resemblance 6 of these curves to 6 That the specific activity-time curves as such may not clearly reveal changes in rates of formation of metabolites is emphasized by the fact that under these steady- 15-MINUTE SAMPLE OF URINE. Each centimeter of paper eluted for analysis. Peaks III, IV, and V estimated by the acid phenylhydrazine reaction and identified further in Figure 5 . I, cortols; II, cortolones; III, THF; IV, allo-THF; V, THE.' Sample is that analyzed in Table II those previously published for a number of normal adults (14) includes: no alteration of the allo-THF specific activity upon administration of unlabeled THF, THE, or /8-cortolone (see Figure  6b) ; a decrease in cortolone specific activity upon addition of unlabeled THF, suggesting some conversion of THF to THE and cortolone (see Figure 6d) ; a decrease in THF and cortolone specific activity upon addition of unlabeled THE, suggesting some conversion of THE to both THF and cortolone (see Figure 6a, Table I ) is not evident from the specific activity-time curves for allo-THF, but is apparent when the low allo-THF pool size is properly included in the-calculated rate of formation.
at the latter's peak (see Figure 6a -c). Because unlabeled THF (see Figure 6a , control) was administered before the maximum in THF specific activity had been reached, the intersection of the cortisol curve with the undiluted THF specific activity curve is not evident. The close similarity however, of the control allo-THF specific activity curve (see Figure 6b) to the THF specific activity curve during the first 2 hours suggested that the control cortisol curve would intersect the theoretical control THF specific activity curve, obtained by extrapolation of the THF curve along the allo-THF curve, at its approximate maximum.
A conversion of THF to THE is not made apparent by this experiment, i.e., it is difficult to discern a fall in THE specific activity after the administration of unlabeled THF. The fall in cortolone specific activity after the administration of unlabeled THE is not so great as that observed in a previous study (14) , presumably because of the smaller quantity of unlabeled diluent administered in the current work.. The pathway from THF to cortol is evident in Figure 7 by the plateau in cortol specific activity after the ad- ministration of unlabeled THF. Unfortunately, the entire cortol curves were not available. As in 6 7 8 the previous study (14) , the slopes of the cortisol specific activity curves and hence, it may be in-THE ferred, the metabolism of cortisol, as such, were -OP: metabolitex--,F----not noticeably altered by the administration of the fco/d,6-CORTOLONE unlabeled metabolites (see Figure 2) . A similar -inference can be made about 6,f-hydroxycortisol (see Figure 9 ).
Amounts excreted, pool sizes, and rates of formation. The data shown in Figure 6 were used to calculate pool sizes and rates of formation of metabolites. Allo-THF excretion. The paucity of allo-THF formation in this patient, in both the post-operative and control periods, is evident in the calculation of pool size (see Table I , b) and is confirmed by the ratio of THF to allo-THF in the excretion of metabolite glucuronides (see Table I , f). Only 2 to 4 per cent of the total THF, allo-THF, and THE excreted is represented by allo-THF in both the control and post-operative periods. This is in marked contrast to the 15 to 30 per cent proportion of allo-THF reported for normal adults (8, 9, 12, 25) .
THF: THE. In Table I , f, the ratios of THF: THE, 3.1 in the post-operative and 2.1 in the control period, are both highly elevated when compared with the values (2 1.0) in normal adults (8, 9, 12, 25) and those (approximately 1.0) in adults stimulated with ACTH (11, 12, 26) . The higher value of the THF: THE ratio in the post-operative as compared with the control period of Table I is consistent with previous findings (12) that a variety of "stress" situations, surgery included, produce elevations in the THF: THE ratio and that this phenomenon involves alterations in the metabolism of cortisol.
Correlation of pool size with excretion data. It is evident from the data presented that the ratios of the calculated pool sizes (see Table I , e) are equal to the relative proportions of the metabolites excreted as glucuronide (see Table I (14) . t Calculated by isotope dilution, unless otherwise indicated, using the decrease in specific activity of the glucuronide fraction (see Figure 6 ) after intravenous administration of unlabeled metabolite.
t Computed before administration of unlabeled metabolite § Calculated from N = ka where N is pool size, a is amount of metabolite excreted per unit time, and k is a proportionality factor calculated from the excretion of THF and THE. This calculation has been discussed elsewhere (14) .
Cortolone includes both 20a and 20fl epimers. ¶ Total radioactivity injected divided by cortisol specific activity extrapolated to time zero. ** Calculated from the integral of the allo-THF specific activities (see Figure 3) . tt Calculated from the integral of the 6,1-hydroxycortisol specific activities (see Figure 9) . ft Since the allo-THF pool size is calculated from urinary excretion data, the pool size ratio equals the urinary ratio, § § Not available, Rates of formation of metabolites. The rates of formation (see Table I (Table III) of the glucuronide fraction (see Ta- ble II, b) demonstrated that 89 per cent of the radioactivity was accounted for by the compounds indicated. These metabolites, 843 jug, approximate the sum of the calculated rates of formation of THF, allo-THF, and THE (see Table I , c), i.e., 99 mg per 24 hours or 1,030 jug per 15 minutes. Hence, it would appear that about 50 per cent of the infused cortisol was excreted as metabolites whose formation proceeded through either THF, allo-THF, or THE. The non-conjugated urine fractions, the glucuronide fractions soluble in carbon tetrachloride and in ethyl acetate, designated I a, b and II a, c in Table II , were exhaustively studied, and a number of highly polar substances, several corresponding in chromatographic mobility to 6,8-hydroxycortisol, 6p8-hydroxycortisone, 20a-DHF, and 20,8-DHF, were observed.
KINETIC ASPECTS OF CORTISOL-4-C4 METABOLISM IN CUSHING'S SYNDROME
Because losses for these metabolites were not ascertainable, however, it was not possible to determine by summation of weights whether these numerous metabolites were equivalent to 1 mg per 15-minute period. It was possible, however, to establish 6,8-hydroxycortisol as the major component of the non-conjugated fraction soluble in ethyl acetate, after chloroform (Ib of Table II) . This extract, when chromatographed in the benzene-butanol system, displayed a radioactive peak whose mobility was identical with that of authentic 6,8-hydroxycortisol. When a portion of creted to determine the specific activity-time curve for this metabolite, and this is shown in Figure 9 for the control period. The curves of Figure 9 are not incompatible with a product-precursor relationship, 8 and hence suggest that in man a major portion of 6,8-hydroxycortisol is derived from cortisol rather than being synthesized directly in the adrenal gland. These suggestions are supported by the observations of Cohn, Upton, and Bondy 8 In steady-state conditions the specific activity curve of the precursor will intersect that of the metabolite at the latter's maximum if theoretical product-precursor relationships hold (15) . Because the slopes of the specific activity curves of Figure 9 change so rapidly, the productprecursor relationship should be considered approximate only. Insert A suggests a product-precursor relationship. Specific activity of F in plasma at time zero is total radioactivity administered/calculated plasma F content. Integral specific activity was determined from the area beneath the semi-log plot (see Figure 3) , and from this the cortisol turnover was 177 mg per 24 hours. Turnover rate for 6p3-hydroxycortisol K = 0.693/ti = 10.5 per 24 hours. Turnover is 10.5 N mg per 24 tisol. Under the steady-state conditions of continuous cortisol infusion reported here, agreement between the turnover of cortisol computed from the specific activity of cortisol curves and the actual rates of infusion of cortisol (see Figure 2 ) was demonstrated.'0 Fortunately, it was possible to calculate the turnover of cortisol in the postoperative period and control periods by applying the equation p = C/SAm (see Figures 3, 9 , and Results) and thus to demonstrate that these calculated values of 203 and 177 mg per 24 hours, respectively, accorded both with the values calculated from the slope of the cortisol specific activity curves and with the actual rates of infusion of cortisol.
Inasmuch as two normal young adults, also turning over cortisol at a rate of 200 mg per 24 hours, were previously (14) shown to have cortisol half-lives of 77 and 88 minutes, it was considered that the half-lives, as such, of 79 and 90 minutes in the control and post-operative periods, respectively, were in no way indicative of an alteration in the metabolism of cortisol in this patient with Cushing's syndrome. 9 The calculated pool sizes in Table I show marked differences from those of two normal individuals studied previously (14) in that the pool sizes of THE and allo-THF are both low, the latter extremely so. These two diminished pool sizes result in high ratios of THF: THE and THF: allo-THF in the urine (see Table I , f).
The heightened values of THF: THE are due presumably to factors other than the high turnover of 200 mg cortisol per 24 hours because the normal adults turning over cortisol at the same rate reached a THF: THE ratio of only 1: 1 (14) . This suggests a partial inhibition in the rate of transformation of cortisol to cortisone in the Cushing's patient.9 The relatively small THE pool sizes, however, found in the face of rates of THE formation almost equivalent to those in the two normal subjects, with rates of 72 and 81 mg 10 Correlation of the infusion rate of cortisol-hemisuccinate with the turnover of cortisol calculated from the miscible cortisol pool demonstrates not only the rapid rate of hydrolysis of the hemisuccinate to "free" cortisol but also the lack of transformation of any significant amount of the steroid nucleus while the compound was still in the hemisuccinate form. Had the latter occurred to a measurable extent, the rate of dilution of the cortisol pool would have been diminished accordingly.
per 24 hours, suggest that a large portion of the THE formed may be further metabolized to compounds other than cortolone. To substantiate such conjecture, transformations of THE into such metabolites must be directly observed in future work. The decrease in the ability to form the 5a isomer, allo-THF, is clear. It results not only in a small allo-THF pool size, but also in a diminished rate of formation of this metabolite (see Table I , c). A diminished excretion of allo-THF appears to be a feature associated with Cushing's syndrome due to adrenal hyperplasia and has been documented by Guignard, Crigler, and Gold (16) .
The application of the Zilversmit equations (15) to the calculation of the rates of formation of the metabolites THF, allo-THF, and THE represented as much as 80 per cent of the turnover of cortisol in two normal adults (14) , whereas in the Cushing's patient (see Table I ) only 50 per cent of the turnover of cortisol was calculated to proceed through these same 3 metabolites. The normal range for the per cent of the turnover of cortisol proceeding through pathways involving these 3 metabolites is not available, although it is interesting to note the variations in recovery of the metabolites of cortisol-4-C14 obtained in a recent thorough quantitative study carried out by Fukushima and co-workers (9) in 5 normal men in 6 experiments. The recovery of radioactivity in the total neutral steroid fraction from the first 24-hour urine samples after the administration of a tracer dose of cortisol-4-C14 was less than 65 per cent of the total radioactivity in the 24-hour urine in 3 of the 6 experiments and as high as 92 per cent in the 3 others. About 50 per cent of the radioactivity in the neutral fractions was located in THF, alo-THF, and THE. with the remainder of the radioactivity existing almost entirely as glycerol-type CG, metabolites. Romanoff In the present study, calculations of the rates of formation of metabolites by means of the Zilversmit equations (15) were carried out only after it was ascertained that steady-state conditions prevailed and that theoretical product-precursor relationships 8, 11 existed for the specific activity curves. It was desirable to determine whether calculations thus made were consistent with the steady-state conditions imposed. Consequently, recovery of radioactivity and amounts in micrograms was performed on the 15-minute urine sample taken 5 hours after cortisol-4-C14 administration in the control period (see Table II 19 ,400 cpm, to about half of the turnover of cortisol. It is this fraction that contains the metabolites of cortisol whose pathways of formation are through THF, allo-THF, and THE.12 This observation is consistent with the Zilversmit calculations, in that the rates of formation of THF, allo-THF, and THF also only account for 50 per cent of the cortisol turnover. In addition, this observation indicates that the remaining 10,000 cpm 13 must be associated with the metabolites equivalent to the remaining 1 mg of cortisol turning over during the 15-minute interval. If there are a number of metabolites of cortisol formed by pathways not involving THF, allo-THF, or THE, then, 13 In Table II , total radioactivity in cpm -II b cpm = 10,000 cpm. from the nature of the product-precursor curves, each of these metabolites will have specific activities greater than that of the cortisol in this sample (15) , where it is (see Figure 2) 7.5 cpm per ,ug. Hence it is possible to have a maximum of 10,000/7.5, or 1.3 mg of metabolite present in the remaining 10,000 cpm.14 The specific activity of 6p-hydroxycortisol in this sample at 300 minutes was 12 cpm per ,^g (see Figure 9) . If the other remaining metabolites had mean specific activities in a similar range, then the turnover of cortisol would be accounted for. It 
